Rubitection is a technology company.
Rubitection has raised $300K across 1 funding round.
Rubitection has raised $300K in total across 1 funding round.
Rubitection has raised $300K in total across 1 funding round.
Rubitection's investors include Luminate Accelerator.
Rubitection is a biotechnology startup developing the Rubitect Assessment System, a low-cost, handheld optical probe paired with AI-powered mobile software for early detection and management of skin conditions like bedsores (pressure ulcers), diabetic foot ulcers, vascular leg ulcers, eczema, psoriasis, and rosacea.[1][2][3][6] It serves caregivers, clinicians, family members, and healthcare professionals in hospitals, nursing homes, home care, dermatology, and wound care settings, solving the problem of unreliable visual skin assessments—especially for diverse skin tones—by providing quantitative measurements of inflammation, temperature, and imaging analysis to enable early intervention, personalized care plans, and prevention of severe outcomes like amputations or sepsis.[3][4][5][6] With 1-10 employees and roots in Pittsburgh, PA, the company targets a $4.2 billion U.S. market while expanding to global skin health monitoring.[1][4]
Founded in 2011, Rubitection emerged from CEO Sanna Gaspard, PhD's doctoral research at Carnegie Mellon University, where she developed a practical skin health assessment tool to address real-world gaps in patient care rather than an academic exercise.[2][3] Motivated by her passion for healthcare impact, diversity in medtech, and fixing biased skin evaluation tools that fail on darker skin tones due to lack of inclusive development teams, Gaspard launched the company to create technology that works for everyone.[3][5] Early focus was on pressure ulcer detection via the Rubitect Assessment System, gaining traction through accelerators like Techstars, AgeTech Collaborative, and partnerships such as InterSystems, while evolving to broader chronic wound and dermatological applications.[1][2][4]
Rubitection rides the wave of AI-driven medtech for aging populations and chronic care, addressing a critical gap in preventive wound management amid rising diabetes, obesity, and elderly care demands—where early bedsores alone cost billions and lead to deadly complications.[4][5] Timing aligns with post-pandemic emphasis on home-based and remote monitoring, inclusive health tech to reduce disparities, and regulatory pushes for quantifiable assessments in reimbursements.[3][4][5] Market tailwinds include biotech investment in non-invasive devices and AI for personalized medicine, positioning Rubitection to influence ecosystems by enabling scalable, equitable skin health tools that cut healthcare costs and improve survival rates (e.g., post-amputation 50-60% five-year rate).[1][5]
Rubitection is poised for expansion through its recent investment push, scaling the Rubitect platform to consumer wellness apps, surgical monitoring, and international markets while deepening AI for predictive analytics.[2][3][6] Trends like aging demographics, telehealth growth, and diversity mandates in health AI will accelerate adoption, potentially evolving it from niche wound care to a ubiquitous skin health standard.[1][5][6] As medtech demands inclusive innovation, Rubitection's equitable approach could redefine caregiving, empowering global users to prevent conditions before they escalate—fulfilling its mission as the go-to system for skin health.[1][3]
Rubitection has raised $300K across 1 funding round. Most recently, it raised $300K Seed in January 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2021 | $300K Seed | Luminate Accelerator |